The scan is done, all pallets are scanned. Now all data are also in the system.
The Scan History meticulously records all FMD operations.
Filter results as desired – e.g. by date.
All results can be downloaded – from CSV to PDF to XLSX.
Using the Lean FMD Control Panel, you have access to the data at all times to edit and export them. Flexible filtering options support you in this:
Whatever use you would like to make of your data – you can be sure they are in good hands with us. We store all data records for the same length of time as the central systems of the NMVS and the EU Hub. The data will remain there for the life of the drug plus one year. The same applies to us, but our storage time is at least 5 years.
Do you need the data beyond this period? Nessun problema. Just let us know.
Should the data be further processed within the company? Do you want to process data internally? All FMD data can be integrated into the company’s IT landscape via an interface. The Lean FMD API is a modern web service interface. With the simplest of commands, you have access to complex data structures.
Whether SAP, Microsoft Dynamics or SAGE: the data structure can easily be read into and evaluated by common ERP systems.
Other common systems can also be given access.
» medAspis lavora per noi fin dall'inizio della direttiva sui farmaci falsificati. Siamo sempre stati colpiti dalla velocità del lavoro. Questo rende il lavoro ancora più veloce e preciso di prima. Gradualmente, abbiamo integrato sempre più funzioni nel nostro sistema informatico. Nel frattempo, tutti i dati importanti vengono inseriti automaticamente nel nostro sistema SAGE. «
Lean FMD works highly efficiently while meeting your high compliance and GxP requirements. With our zero-alert strategy, there are virtually no more false alarms reported to the authorities. Only extremely few real suspected counterfeit cases remain. In these cases, we support you with our unique know-how and provide the right solution: from practical instructions for scanning staff to the professional handling of critical counterfeiting suspicions. Thus, there is no reason for the authorities to examine the issue of FMD more closely during the next audit.